Bill Text: GA SB353 | 2009-2010 | Regular Session | Engrossed

---

Bill Title: Controlled Substances; Schedule I, II, IV, and V; definition of "dangerous drug"; provisions

Spectrum: Partisan Bill (Republican 2-0)

Status: (Passed) 2010-06-03 - Effective Date [SB353 Detail]

Download: Georgia-2009-SB353-Engrossed.html

---

10

Senate Bill 353

By: Senators Carter of the 1st and Thomas of the 54th

AS PASSED SENATE

A BILL TO BE ENTITLED
AN ACT

To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to change certain provisions relating to Schedule I, II, IV, and V controlled substances; to change certain provisions relating to the definition of "dangerous drug"; to provide an effective date; to repeal conflicting laws; and for other purposes.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:

SECTION 1.

Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, is amended in Code Section 16-13-25, relating to Schedule I controlled substances, by revising subparagraph (SS) of paragraph (3) as follows:

"(SS) Reserved Chlorophenylpiperazine (CPP);"

SECTION 2.

Said chapter is further amended in Code Section 16-13-26, relating to Schedule II controlled substances, by adding a new subparagraph to paragraph (2) to read as follows:

"(V.1) Tapentadol;"

SECTION 3.

Said chapter is further amended in Code Section 16-13-28, relating to Schedule IV controlled substances, by adding a new paragraph to subsection (a) to read as follows:

"(15.3) Fospropofol;"

SECTION 4.

Said chapter is further amended in Code Section 16-13-29, relating to Schedule V controlled substances, by revising paragraph (2) as follows:

"(2) Reserved Lacosamide;"

SECTION 5.

Said chapter is further amended in Code Section 16-13-71, relating to the definition of dangerous drug, by revising paragraph (512.5) of subsection (b) as follows:

"(512.5) Lansoprazole - see exceptions;"

SECTION 6.

Said chapter is further amended in Code Section 16-13-71, relating to the definition of dangerous drug, by adding new paragraphs to subsection (b) to read as follows:

"(.043) abobotulinumtoxinA;"

"(65.5) Artemether;"

"(66.5) Asenapine;"

"(91.3) Bepotastine;"

"(91.8) Besifloxacin;"

"(130.3) Canakinumab;"

"(133.05) Capsaicin - see exceptions;"

"(209.5) Colesevelam;"

"(244.4) Degarelix;"

"(259.5) Dexlansoprazole;"

"(324.5) Dronedarone;"

"(328.5) Ecallantide;"

"(380.3) Everolimus;"

"(382.25) Febuxostat;"

"(383.43) Ferumoxytol;"

"(408.35) Gadofosveset;"

"(424.4) Golimumab;"

"(464.67) Iloperidone;"

"(531.5) Lumefantrine;"

"(617.47) Milnacipran;"

"(661.6) Ofatumumab;"

"(692.3) Pazopanib;"

"(740.5) Pitavastatin;"

"(768.8) Pralatrexate;"

"(769.35) Prasugrel;"

"(845.1) Romidepsin;"

"(851.7) Saxagliptin;"

"(931.555) Telavancin;"

"(969.6) Tocilizumab;"

"(973.07) Tolvaptan;"

"(1021.6) Ustekinumab;"

"(1030.3) Vigabatrin;"

SECTION 7.

Said chapter is further amended in Code Section 16-13-71, relating to the definition of dangerous drug, by adding a new paragraph to subsection (c) to read as follows:

"(6.45) Capsaicin - when in an external analgesic with concentration of 0.25 percent or less;"

"(12.9) Lansoprazole – when a single dosage unit is 15 mg. or less;"

SECTION 8.

This Act shall become effective upon its approval by the Governor or upon its becoming law without such approval.

SECTION 9.

All laws and parts of laws in conflict with this Act are repealed.